Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Itzler

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Journal of Medical Economics|September 17, 2011
Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in TaiwanRobbin F Itzler, Po Yen Chen, Christina Lac, et al.
The Review of Scientific Instruments|August 3, 2012
An ultra low noise telecom wavelength free running single photon detector using negative feedback avalanche diodeZhizhong Yan, Deny R Hamel, Aimee K Heinrichs, et al.
Clinical Transplantation|May 6, 2021
Incidence, risk factors, and long-term outcomes associated with antibody-mediated rejection - The long-term Deterioration of Kidney Allograft Function (DeKAF) prospective cohort studyAllyson Hart, David P Schladt, Arthur J Matas, et al.
The Pediatric Infectious Disease Journal|December 2, 2009
Efficacy and safety of pentavalent human-bovine reassortant rotavirus vaccine when administered with greater than 10 weeks between dosesMichelle G Goveia, Leora Suprun, Robbin F Itzler, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST)David O Matson, Timo Vesikari, Penelope Dennehy, et al.
Orphanet Journal of Rare Diseases|June 22, 2024
An international survey assessing the effects of the duration of attack-free period on health-related quality of life for patients with hereditary angioedemaRobbin Itzler, William R Lumry, John Sears, et al.
Mayo Clinic Proceedings|September 2, 2009
Health care utilization and cost burden of herpes zoster in a community populationBarbara P Yawn, Robbin F Itzler, Peter C Wollan, et al.
BMC Pediatrics|June 15, 2010
Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)Robbin Itzler, Gary Koch, David O Matson, et al.
International Journal of Cardiology|October 16, 2003
National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United KingdomAmeet Bakhai, Marcus D Flather, Julian R Collinson, et al.
Transplantation and Cellular Therapy|September 19, 2021
Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and OutcomesNosha Farhadfar, Helen L Leather, Shu Wang, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Journal of Medical Economics|September 17, 2011
Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in TaiwanRobbin F Itzler, Po Yen Chen, Christina Lac, et al.
The Review of Scientific Instruments|August 3, 2012
An ultra low noise telecom wavelength free running single photon detector using negative feedback avalanche diodeZhizhong Yan, Deny R Hamel, Aimee K Heinrichs, et al.
Clinical Transplantation|May 6, 2021
Incidence, risk factors, and long-term outcomes associated with antibody-mediated rejection - The long-term Deterioration of Kidney Allograft Function (DeKAF) prospective cohort studyAllyson Hart, David P Schladt, Arthur J Matas, et al.
The Pediatric Infectious Disease Journal|December 2, 2009
Efficacy and safety of pentavalent human-bovine reassortant rotavirus vaccine when administered with greater than 10 weeks between dosesMichelle G Goveia, Leora Suprun, Robbin F Itzler, et al.
Human Vaccines & Immunotherapeutics|November 27, 2014
Analysis by rotavirus gene 6 reverse transcriptase-polymerase chain reaction assay of rotavirus-positive gastroenteritis cases observed during the vaccination phase of the Rotavirus Efficacy and Safety Trial (REST)David O Matson, Timo Vesikari, Penelope Dennehy, et al.
Orphanet Journal of Rare Diseases|June 22, 2024
An international survey assessing the effects of the duration of attack-free period on health-related quality of life for patients with hereditary angioedemaRobbin Itzler, William R Lumry, John Sears, et al.
Mayo Clinic Proceedings|September 2, 2009
Health care utilization and cost burden of herpes zoster in a community populationBarbara P Yawn, Robbin F Itzler, Peter C Wollan, et al.
BMC Pediatrics|June 15, 2010
Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5)Robbin Itzler, Gary Koch, David O Matson, et al.
International Journal of Cardiology|October 16, 2003
National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United KingdomAmeet Bakhai, Marcus D Flather, Julian R Collinson, et al.
Transplantation and Cellular Therapy|September 19, 2021
Severity of Acute Graft-versus-Host Disease and Associated Healthcare Resource Utilization, Cost, and OutcomesNosha Farhadfar, Helen L Leather, Shu Wang, et al.
Pageof 5